Latest Financials News

Toubani Resources has locked in a transformative A$395 million funding package to advance its Kobada Gold Project in Mali, setting the stage for production to commence by the third quarter of 2027.

Pacgold Limited’s trading suspension has been lifted following its announcement of a capital raising, signaling renewed market activity for the gold explorer.

Pacgold Limited announces acquisition and phased restart of the White Dam gold project, targeting near-term production and resource expansion with a $12.4 million funding plan.

Polymetals Resources has advanced its Endeavor Mine ramp-up, producing over 15,000 tonnes of concentrates and scheduling its first zinc shipment. The company also reduced debt and strengthened its cash position, signaling progress toward steady-state operations.

Buru Energy secured key government approvals and identified a promising new gas prospect beneath its Rafael field, while raising $4.4 million to fund development activities. The company is gearing up for a Final Investment Decision in 3Q 2026, aiming for first material cash flow by 2028.

Kairos Minerals has finalized a pivotal mineral rights agreement with Pilbara Minerals, granting it extensive rights over key Pilbara licences and setting the stage for a significant drilling campaign to expand its Mt York gold resource.

Pacific Smiles Group Limited has issued a Target’s Statement endorsing Beam Dental Bidco’s $2.20 per share off-market takeover bid. The Independent Expert deems the offer fair and reasonable, and the Independent Board Committee urges shareholders to accept, barring a superior proposal.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Findi Limited has responded to ASX inquiries about unusual stock price and volume movements, denying any undisclosed information and announcing legal action against a former subsidiary executive for misleading social media posts.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

Orthocell Limited has reported a record $3 million quarterly revenue, driven by strong sales of its nerve repair product Remplir in Australia and Singapore, while advancing its rollout in the US and Canada ahead of schedule.

Beam Dental Bidco Pty Ltd has launched an unconditional $2.20 per share takeover bid for Pacific Smiles Group Limited, offering a 37.5% premium and aiming to consolidate full ownership. The offer is unanimously recommended by Pacific Smiles’ Independent Board Committee, with plans to delist the company from the ASX upon success.